Best supportive care (BSC) versus oxaliplatin, folinic acid and 5-fluorouracil (OFF) plus BSC in patients for second-line advanced pancreatic cancer: a phase III-study from the German CONKO-study group - Pelzer, U; Schwaner, I; Stieler, J (Eur J Cancer, 2011)
et al.